Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues

References

• WHO chief declares end to COVID-19 as a global health emergency | UN News; 2023. https://news.un.org/en/story/2023/05/1136367.
   Google Scholar
• Kingwell K. COVID vaccines: “we flew the aeroplane while we were still building it. Nat Rev Drug Discov. 2022;21(12):1–6.
   PubMed Web of Science ®Google Scholar
• Pezzullo AM, Axfors C, Contopoulos-Ioannidis DG, et al. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023;216(Pt 3):114655.
   PubMedGoogle Scholar
• Chemaitelly H, Ayoub HH, AlMukdad S, et al. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study. Lancet Microbe. 2022;3(12):e944–e955.
   PubMedGoogle Scholar
• Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) 174th Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting; 2022. https://www.fda.gov/media/161064/download.
   Google Scholar
• CDC. 2020. COVID-19 vaccination. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/overview-COVID-19-vaccines.html.
   Google Scholar
• Safe COVID-19 vaccines for Europeans | European Commission. https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid-19-vaccines-europeans_en.
   Google Scholar
• Cagigi A, Loré K. Immune responses induced by mRNA vaccination in mice, monkeys and humans. Vaccines (Basel). 2021;9(1):61.
   PubMed Web of Science ®Google Scholar
• Mascellino MT, Di Timoteo F, De Angelis M, et al. Overview of the main Anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist. 2021;14:3459–3476.
   PubMed Web of Science ®Google Scholar
• 2021. EMA. 2020a. Assessment report Comirnaty Common name: COVID-19 mRNA vaccine (nucleosidemodified) [WWW Document]. https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-repo rt_en.pdf.
   Google Scholar
• Polykretis P. Role of the antigen presentation process in the immunization mechanism of the genetic vaccines against COVID-19 and the need for biodistribution evaluations. Scand J Immunol. 2022;96(2):e13160.
   PubMed Web of Science ®Google Scholar
• Rock KL, Reits E, Neefjes J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 2016;37(11):724–737.
   PubMed Web of Science ®Google Scholar
• Kotsias F, Cebrian I, Alloatti A. Antigen processing and presentation. Int Rev Cell Mol Biol. 2019;348:69–121.
   PubMed Web of Science ®Google Scholar
• Polykretis P. Advanced glycation end-products as potential triggering factors of self-reactivity against myelin antigens in multiple sclerosis. Med Hypotheses. 2021;157:110702.
   PubMed Web of Science ®Google Scholar
• Autoimmune damage to the nerves following Covid vaccines: EMA issued warning to patients and healthcare professionals; 2021. https://www.bmj.com/content/374/bmj.n1786/rr-0.
   Google Scholar
• Doshi P. Covid-19 vaccines: in the rush for regulatory approval, do we need more data? BMJ. 2021;373:n1244.
   PubMedGoogle Scholar
• Blaylock RL. COVID update: what is the truth? Surg Neurol Int. 2022;13:167.
   PubMedGoogle Scholar
• Cosentino M, Marino F. Understanding the pharmacology of COVID-19 mRNA vaccines: playing dice with the spike? Int J Mol Sci. 2022;23(18):10881.
   PubMed Web of Science ®Google Scholar
• Banoun H. mRNA: vaccine or gene therapy? The safety regulatory issues. Int J Mol Sci. 2023;24(13):10514.
   PubMed Web of Science ®Google Scholar
• Polykretis P, McCullough PA. Rational harm-benefit assessments by age group are required for continued COVID-19 vaccination. Scand J Immunol. 2023;98(1):e13242.
   PubMed Web of Science ®Google Scholar
• https://phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf.
   Google Scholar
• Fertig TE, Chitoiu L, Marta DS, et al. Vaccine mRNA can be detected in blood at 15 days post-vaccination. Biomedicines. 2022;10(7):1538.
   PubMed Web of Science ®Google Scholar
• Yonker LM, Swank Z, Bartsch YC, et al. Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis. Circulation. 2023;147:867–876.
   Web of Science ®Google Scholar
• Bansal S, Perincheri S, Fleming T, et al. Cutting edge: circulating exosomes with COVID spike protein are induced by BNT162b2 (Pfizer-BioNTech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J Immunol. 2021;207(10):2405–2410.
   PubMed Web of Science ®Google Scholar
• Hanna N, Heffes-Doon A, Lin X, et al. Detection of messenger RNA COVID-19 vaccines in human breast milk. JAMA Pediatr. 2022;176(12):1268–1270.
   PubMed Web of Science ®Google Scholar
• Röltgen K, Nielsen SCA, Silva O, et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185(6):1025–1040.e14.
   PubMed Web of Science ®Google Scholar
• Sanders J. Which lasts longer, spike proteins or CDC ‘facts?’ | AIER. https://www.aier.org/article/which-last-longer-spike-proteins-or-cdc-facts.
   Google Scholar
• Maugeri M, Nawaz M, Papadimitriou A, et al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat Commun. 2019;10(1):4333.
   PubMed Web of Science ®Google Scholar
• Mishra R, Banerjea AC. SARS-CoV-2 spike targets USP33-IRF9 axis via exosomal miR-148a to activate human microglia. Front Immunol. 2021;12:656700.
   PubMed Web of Science ®Google Scholar
• Fernández-Messina L, Rodríguez-Galán A, de Yébenes VG, et al. Transfer of extracellular vesicle-microRNA controls germinal center reaction and antibody production. EMBO Rep. 2020;21:e48925.
   PubMed Web of Science ®Google Scholar
• Seneff S, Nigh G, Kyriakopoulos AM, et al. Innate immune suppression by SARS-CoV-2 mRNA vaccinations: the role of G-quadruplexes, exosomes, and MicroRNAs. Food Chem Toxicol. 2022;164:113008.
   PubMed Web of Science ®Google Scholar
• Pittoggi C, Beraldi R, Sciamanna I, et al. Generation of biologically active retro-genes upon interaction of mouse spermatozoa with exogenous DNA. Mol Reprod Dev. 2006;73(10):1239–1246.
   PubMed Web of Science ®Google Scholar
• Spadafora C. Sperm-mediated “reverse” gene transfer: a role of reverse transcriptase in the generation of new genetic information. Hum Reprod. 2008;23(4):735–740.
   PubMed Web of Science ®Google Scholar
• Parrington J, Coward K, Gadea J. Sperm and testis mediated DNA transfer as a means of gene therapy. Syst Biol Reprod Med. 2011;57(1-2):35–42.
   PubMed Web of Science ®Google Scholar
• Spadafora C. Sperm-mediated transgenerational inheritance. Front Microbiol. 2017;8:2401.
   PubMed Web of Science ®Google Scholar
• O’Brien EA, Ensbey KS, Day BW, et al. Direct evidence for transport of RNA from the mouse brain to the germline and offspring. BMC Biol. 2020;18(1):45.
   PubMed Web of Science ®Google Scholar
• Aldén M, Olofsson Falla F, Yang D, et al. Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 In vitro in human liver cell line. Curr Issues Mol Biol. 2022;44(3):1115–1126.
   PubMed Web of Science ®Google Scholar
• Baumeier C, Aleshcheva G, Harms D, et al. Intramyocardial inflammation after COVID-19 vaccination: an endomyocardial biopsy-proven case series. Int J Mol Sci. 2022;23(13):6940.
   PubMed Web of Science ®Google Scholar
• Schwab C, Domke LM, Hartmann L, et al. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol. 2023;112(3):431–440.
   PubMed Web of Science ®Google Scholar
• Mörz M. A case report: multifocal necrotizing encephalitis and myocarditis after BNT162b2 mRNA vaccination against COVID-19. Vaccines (Basel). 2022;10(10):1651.
   PubMed Web of Science ®Google Scholar
• Nushida H, Ito A, Kurata H, et al. A case of fatal multi-organ inflammation following COVID-19 vaccination. Leg Med (Tokyo). 2023;63:102244.
   PubMed Web of Science ®Google Scholar
• Prof. Arne Burkhardt. “Current Findings on Vaccination Adverse Reactions.” 2nd Medical Symposium. Sept 18th, 2022; https://www.bitchute.com/video/vGstfdSOt3rO/.
   Google Scholar
• Yamamoto M, Kase M, Sano H, et al. Persistent varicella zoster virus infection following mRNA COVID-19 vaccination was associated with the presence of encoded spike protein in the lesion. J Cutaneous Imm Allergy. 2023;6(1):18–23.
   Google Scholar
• Reinfeld S, Cáceda R, Gil R, et al. Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report. Psychiatry Res. 2021;304:114165.
   PubMed Web of Science ®Google Scholar
• Singh S, Sanna F, Adhikari R, et al. Chronic inflammatory demyelinating polyneuropathy post-mRNA-1273 vaccination. Cureus. 2022;14(4):e24528.
   PubMed Web of Science ®Google Scholar
• Toljan K, Amin M, Kunchok A, et al. New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure. J Neuroimmunol. 2022;362:577785.
   PubMed Web of Science ®Google Scholar
• Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022;145(1):5–9.
   PubMed Web of Science ®Google Scholar
• Kyriakopoulos AM, Mccullough PA, Nigh G, et al. Potential mechanisms for human genome integration of genetic code from SARS-CoV-2 mRNA vaccination. Authorea. September 01, 2022; doi: 10.22541/au.166203678.82079667/v1.
   Google Scholar
• Kyriakopoulos AM, Nigh G, McCullough PA, et al. Mitogen activated protein kinase (MAPK) activation, p53, and autophagy inhibition characterize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein induced neurotoxicity. Cureus. 2022;14(12):e32361.
   PubMed Web of Science ®Google Scholar
• Fierabracci A, Pellegrino M. The double role of p53 in cancer and autoimmunity and its potential as therapeutic target. Int J Mol Sci. 2016;17(12):1975.
   PubMed Web of Science ®Google Scholar
• Sacchi MC, Pelazza C, Bertolotti M, et al. The onset of de novo autoantibodies in healthcare workers after mRNA based anti-SARS-CoV-2 vaccines: a single Centre prospective follow-up study. Autoimmunity. 2023;56(1):2229072.
   PubMed Web of Science ®Google Scholar
• Ogata AF, Cheng C-A, Desjardins M, et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clinical Infectious Diseases ciab465. 2022;74(4):715–718.
   PubMed Web of Science ®Google Scholar
• Cognetti JS, Miller BL. Monitoring serum spike protein with disposable photonic biosensors Following SARS-CoV-2 vaccination. Sensors (Basel). 2021;21(17):5857.
   PubMed Web of Science ®Google Scholar
• Boschi C, Scheim DE, Bancod A, et al. SARS-CoV-2 spike protein induces hemagglutination: implications for COVID-19 morbidities and therapeutics and for vaccine adverse effects. Int J Mol Sci. 2022;23(24):15480.
   PubMed Web of Science ®Google Scholar
• Bellavite P. Renin-angiotensin system, SARS-CoV-2 and hypotheses about some adverse effects following vaccination. EC Pharmacology and Toxicology. 2021;9(4):1–10.
   Google Scholar
• Angeli F, Reboldi G, Trapasso M, et al. COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the “spike effect.” Eur J Intern Med. 2022;103:23–28.
   PubMed Web of Science ®Google Scholar
• Bellavite P, Ferraresi A, Isidoro C. Immune response and molecular mechanisms of cardiovascular adverse effects of spike proteins from SARS-CoV-2 and mRNA vaccines. Biomedicines. 2023;11(2):451.
   PubMed Web of Science ®Google Scholar
• Perico L, Morigi M, Galbusera M, et al. SARS-CoV-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation. Front Immunol. 2022;13:827146.
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Giovanellla L, Campennì A. SARS-CoV-2 vaccine may trigger thyroid autoimmunity: real-life experience and review of the literature. J Endocrinol Invest. 2022;45(12):2283–2289.
   PubMed Web of Science ®Google Scholar
• Vuille-Lessard É, Montani M, Bosch J, et al. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021;123:102710.
   PubMed Web of Science ®Google Scholar
• Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic events after COVID-19 vaccination. Autoimmun Rev. 2021;20(11):102941.
   PubMed Web of Science ®Google Scholar
• Kwon H, Kim T. Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination. Neurol Sci. 2022;43(3):1487–1489.
   PubMed Web of Science ®Google Scholar
• Bril F, Al Diffalha S, Dean M, et al. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty? J Hepatol. 2021;75(4):996–997.
   PubMed Web of Science ®Google Scholar
• Portuguese AJ, Sunga C, Kruse-Jarres R, et al. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv. 2021;5(13):2794–2798.
   PubMed Web of Science ®Google Scholar
• Kaulen LD, Doubrovinskaia S, Mooshage C, et al. Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case series. Eur J Neurol. 2022;29(2):555–563.
   PubMed Web of Science ®Google Scholar
• Chamling B, Vehof V, Drakos S, et al. Occurrence of acute infarct-like myocarditis following COVID-19 vaccination: just an accidental co-incidence or rather vaccination-associated autoimmune myocarditis? Clin Res Cardiol. 2021;110(11):1850–1854.
   PubMed Web of Science ®Google Scholar
• Ghielmetti M, Schaufelberger HD, Mieli-Vergani G, et al. Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: a novel clinical entity? J Autoimmun. 2021;123:102706.
   PubMed Web of Science ®Google Scholar
• Garrido I, Lopes S, Simões MS, et al. Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence. J Autoimmun. 2021;125:102741.
   PubMed Web of Science ®Google Scholar
• Clayton-Chubb D, Schneider D, Freeman E, et al. Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. J Hepatol. 2021;75(5):1249–1250.
   PubMed Web of Science ®Google Scholar
• Gadi SRV, Brunker PAR, Al-Samkari H, et al. Severe autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine. Transfusion. 2021;61(11):3267–3271.
   PubMed Web of Science ®Google Scholar
• Fatima Z, Reece BRA, Moore JS, et al. Autoimmune hemolytic anemia after mRNA COVID vaccine. J Investig Med High Impact Case Rep. 2022;10:23247096211073258.
   Web of Science ®Google Scholar
• Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021;9(5):435.
   PubMed Web of Science ®Google Scholar
• Minocha PK, Better D, Singh RK, et al. Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. J Pediatr. 2021;238:321–323.
   PubMed Web of Science ®Google Scholar
• Mahroum N, Lavine N, Ohayon A, et al. COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: insights from a narrative literature review. Front Immunol. 2022;13:872683.
   PubMed Web of Science ®Google Scholar
• Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022;43(1):3–40.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386–401.
   PubMed Web of Science ®Google Scholar
• BNT162b2 Module 2.4. Nonclinical Overview. https://phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_24_nonclinical-overview.pdf.
   Google Scholar
• 2022. June 23, 2022 ACIP Meeting – Votes. https://www.youtube.com/watch?v=iZTuP806RTU.
   Google Scholar
• Salerno M, Sessa F, Piscopo A, et al. No autopsies on COVID-19 deaths: a missed opportunity and the lockdown of science. J Clin Med. 2020;9(5):1472.
   PubMed Web of Science ®Google Scholar
• Mansanguan S, Charunwatthana P, Piyaphanee W, et al. Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents. Trop Med Infect Dis. 2022;7(8):196.
   PubMedGoogle Scholar
• Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination. presentation at ESC Congress 2022. https://esc365.escardio.org/presentation/255414.
   Google Scholar
• Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics. 2021;148(3):e2021052478.
   PubMed Web of Science ®Google Scholar
• Wise J. Covid-19: should we be worried about reports of myocarditis and pericarditis after mRNA vaccines? BMJ. 2021;373:n1635.
   PubMedGoogle Scholar
• Choi S, Lee S, Seo J-W, et al. Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 vaccination in Korea: Case report focusing on histopathological findings. J Korean Med Sci. 2021;36(40):e286.
   PubMed Web of Science ®Google Scholar
• Gill JR, Tashjian R, Duncanson E. Autopsy histopathologic cardiac findings in 2 adolescents following the second COVID-19 vaccine dose. Arch Pathol Lab Med. 2022;146(8):925–929.
   PubMedGoogle Scholar